# The Clinical Carbetocin Myocardium Trial

> **NCT02528136** · PHASE4 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DRUG:** Carbetocin
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT02528136
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-01-28
- **Final completion:** 2019-01-28
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02528136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02528136, "The Clinical Carbetocin Myocardium Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02528136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*